Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease [Phase 2]
A Phase 2 long-term safety study of ND0612 delivered by continuous subcutaneous infusion in advanced Parkinson's disease has results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD [Phase 3]
A Phase 3 study completed evaluating the effectiveness and safety of LY03003 in patients with early primary Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Antidepressants Trial in Parkinson's Disease [Phase 3]
Phase 3 clinical trial investigating antidepressants for depression in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluated relative bioavailability of ropinirole implants versus oral ropinirole in Parkinson's disease patient…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Chronic Effects of DBS in Parkinson's Disease and Dystonia [NA]
Clinical trial update on chronic effects of deep brain stimulation in Parkinson's disease and dystonia, with completed status and posted res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: PPMI Tau PET Imaging [Phase 2]
Phase 2 trial update on tau PET imaging in Parkinson's disease completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease [Phase 3]
Phase 3 clinical trial evaluating buspirone for treatment of iatrogenic dyskinesias in advanced Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease [Phase 2, Phase 3]
Clinical trial evaluating safety and tolerability of hydrogen in Parkinson's disease was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating OC Oral Solution for reducing sialorrhoea in Parkinson's disease; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating safety, tolerability, and efficacy of two daily doses of P2B001 in early Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic [Phase 2]
A Phase 2 clinical trial investigates a multi-strain probiotic to treat anxiety in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Physical Therapy and Deep Brain Stimulation in Parkinson Disease [NA]
A completed clinical trial evaluating physical therapy and deep brain stimulation in Parkinson disease with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: A Phase 3 Study With P2B001 in Subjects With Early Parkinson's [Phase 3]
Phase 3 trial completed for P2B001 in early Parkinson's disease with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Parkinson's Disease Inpatient Clinical Knowledge and Management [NA]
A terminated clinical trial related to Parkinson disease with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study [Phase 4]
A Phase 4 crossover trial comparing Parcopa to carbidopa-levodopa in Parkinson's disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD) [Phase 2]
Phase 2 clinical trial evaluating an abdominal binder to treat orthostatic hypotension in Parkinson's disease has completed with results pos…
-
FDA approval · 2023-02-28FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Alembic Pharmaceuticals Limited, expanding the availability of …
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients [Phase 1, Phase 2]
Phase 1/2 dose-finding biomarker trial of Posiphen in early Alzheimer's and Parkinson's patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Effect of SQJZ Herbal Mixtures on Non-motor Symptoms of Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating SQJZ herbal mixtures for non-motor symptoms in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease [Phase 4]
Phase 4 clinical trial update exploring the role and mechanism of probiotics in improving motor symptoms in mild to moderate Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: FitMi PD Home Therapy for Parkinson's Disease [NA]
A completed clinical trial update for FitMi PD Home Therapy in Parkinson's disease with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease [Phase 4]
A Phase 4 clinical trial update for Stalevo in early Parkinson's disease is listed with unknown status but ongoing investigation.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations [Phase 3]
Phase 3 study evaluating IPX203 for Parkinson's disease with motor fluctuations has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa [Phase 1, Phase 2]
Phase 1/2 clinical trial update on NE3107 for Parkinson's disease patients using levodopa, evaluating activity and safety.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: taVNS in Mild to Moderate Parkinson's Disease [NA]
Completed clinical trial of transcutaneous auricular vagus nerve stimulation (taVNS) in mild to moderate Parkinson's disease with results po…